For CD8+ cytotoxic T cells to be able to recognize and kill cancer cells, they first need to be activated and primed by recognition of tumor-derived antigens, presented by antigen presenting cells (APCs) such as dendritic cells (DCs). This evidence concerns the gene CD8A and neoplasm.